Nine-Valent Human Papillomavirus Vaccination and Related Cancers in Males - PubMed
3 hours ago
- #public health
- #HPV vaccine
- #cancer prevention
- Nine-valent HPV vaccination reduces risk of HPV-related cancers in males.
- Study involved over 500,000 matched pairs of vaccinated and unvaccinated males aged 9-26.
- Hazard ratio for primary composite outcome was 0.54 (95% CI 0.37-0.81).
- Significant risk reduction observed in both younger (9-14 years) and older (15-26 years) age groups.